Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.
about
Biosynthesis and Functional Significance of Peripheral Node Addressin in Cancer-Associated TLOCheckpoint Inhibitors and Their Application in Breast CancerBiomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrateMeta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome.Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies.Autocrine signaling of type 1 interferons in successful anticancer chemotherapyRepeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model.A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways.Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.Chemosensitization strategies for the treatment of lung cancer.Extracting tumor tissue immune status from expression profiles: correlating renal cancer prognosis with tumor-associated immunome.Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: A microarray-based meta-analysis.Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy.Improvement of immunogenic chemotherapy by STAT3 inhibition.The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1.Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune Responsiveness.Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer.Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer.The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial Carcinoma.CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancerIdentification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade.A review of the importance of immune responses in luminal B breast cancer.Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysisIdentifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.The immune contexture in cancer prognosis and treatment.The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ.Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.Immune infiltrate in cancerPro-necrotic molecules impact local immunosurveillance in human breast cancer.Consensus guidelines for the detection of immunogenic cell death.Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma.Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.The renaissance of anti-neoplastic immunity from tumor cell demise.Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy.Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment.Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts
P2860
Q26739445-5DC5CA0E-0672-4D13-8054-F9B96367C7AFQ26745442-CEA54381-85F1-4D87-ADDC-DF80F8A2A934Q30276247-DB8AF3CC-749C-4877-81B1-8D662A1287A2Q34372945-C8E7964E-6169-47D8-A1C4-019E8AD7F6C6Q35789363-A58BF1F5-FF99-4FDF-8AA7-047F0567B4C0Q35828467-52BAD876-CA3C-42E1-8328-3B16BDF15E9AQ36060217-0339A318-0E32-4837-9ECB-EF8E7D222E04Q36137504-FA7C5F4D-A148-4A3B-97D4-907FC9218F4CQ36231343-B4E3A56A-4CD1-4E13-8AE3-C7F262CFA024Q36301061-BB8D0C51-A48E-4956-B6DC-1D4B04947202Q36352608-9E205FAB-5DA0-456C-8799-44D8E460D690Q36545108-600F2B49-F046-4324-A2E9-73BA72D8E40BQ36710922-1405168B-4209-4428-87A8-9BFEC7E2AEDDQ36710945-90BE3DE2-023A-43F3-8AFE-7F917BFB03F6Q36710966-F25EF2BC-1A7B-41D3-9C2F-1AEC76917650Q36862687-325CB4DD-480F-4BE1-87EE-C680B80D34E0Q37012744-341F6C5C-75FD-4CCC-B33C-75B31438B607Q37059747-8BDFF2E3-EACD-4896-B396-843B7A65A59BQ37079087-A082AD6E-0D62-48F0-B3ED-9746C4015B3BQ37222093-5D5C6606-426F-4D25-98A7-BD3892253346Q37530339-88E57847-A79B-4F82-BA03-3A0C276031CAQ38751056-AD7EAD30-C911-425B-B865-13F1D76FB5AFQ38875037-F2D58069-BAAC-4BA8-9DFD-A530B14417A3Q38998454-7ADBB413-64DA-4197-8311-E7442C832662Q39239484-32596C32-6723-40B0-9F60-F0BB20C90D86Q39281286-1BE785B2-E8BC-4BBB-ABF9-24B19A70E466Q39313889-6C4A27CC-A945-4EC7-A945-13DD0E78DED1Q39456999-E2BCCB3E-D1A0-4646-82A8-C6CF01CF01A0Q41625138-55963BB8-8613-48E4-9231-0EC8EEF8FB2FQ41660755-3A5A6AB9-CF6B-448B-9E0D-E1E4C8E941CCQ42348830-3BAACE5F-F547-4D2F-AC6B-B72518AF4BEAQ42509779-70287A4D-9C3F-479E-A8E6-8D9CC5F3C5C9Q42553556-3288A0B0-1344-462B-82E4-32D535C40CDBQ47401128-527AA845-485A-4747-AB79-A8E95523EC7CQ47614555-D2FC1946-FF6C-445C-9B6A-15F49BD43495Q48193643-1821E111-C344-4D97-904D-E6FF4F9BEB7AQ50044364-23B58D9A-E466-42E4-A73F-92E4DE97679FQ52725437-CE0C59F9-A87E-4DCB-A5DD-CC5B4E62A917Q57082684-090DC1A4-A33F-45A6-828F-1F8602010488
P2860
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.
@en
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.
@nl
type
label
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.
@en
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.
@nl
prefLabel
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.
@en
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.
@nl
P2860
P50
P356
P1433
P1476
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.
@en
P2093
Bernhard Mlecnik
David Enot
P2860
P304
P356
10.4161/ONCI.27884
P577
2014-01-01T00:00:00Z